Adjö — My Patient’s Prolonged Good-Bye
"Do you know how to say au revoir in Swedish?” His eyes light up like miniature moons, cataracts shimmering with childish joy. His lips pull back into a smile, revealing teeth browned and loosened from their foundation. His mind, having churned thought after thought for 95 years, can’t keep up now, so he asks me this same question at every clinic visit. I smile and pretend I’m answering for the first time. Every time.
New Chair of Orthopaedics and Rehabilitation Has Ambitious Goals for Department
Lisa Lattanza, MD, the new chair of Orthopaedics and Rehabilitation, wants to help create a nationally prominent orthopaedics practice at Yale with destination programs, unique collaborations, and such advanced procedures as 3D cellular printing of bone and cartilage.
Yale Cancer Center Researchers Investigate Inducing “Synthetic Lethality” in Two Blood and Bone Cancers
In a clinical trial led by Yale Cancer Center (YCC) and Smilow Cancer Hospital, researchers aim to exploit DNA mutations in the treatment of two blood and bone marrow cancers, a different tacit than the more traditional approach of blunting or switching off genetic mutations linked to cancer.
Yale Cancer Center study shows Artificial Intelligence can help radiologists find microscopic evidence of advancing head and neck cancer
New findings by researchers at Yale Cancer Center (YCC) show deep learning algorithms can outperforms radiologists in finding microscopic infiltrations of head and neck cancer in lymph nodes.
Scientist or Entrepreneur? Blavatnik Fund Lets Yale Researchers Be Both
Turning a discovery into a life-saving commercial product requires funding at every stage — proof-of-concept, animal tests, clinical trials. And the initial phase — the one between discovery and proof of concept — is often the hardest for faculty to overcome.
Yale Cancer Center study suggests new approaches needed to manage ibrutinib-related toxicities in CLL patients
New findings by Yale Cancer Center (YCC) and Smilow Cancer Hospital researchers show that as the use of the drug ibrutinib climbs in patients with chronic lymphocytic leukemia (CLL), so do the rates of patients who stop taking the drug.
Yale Cancer Center researchers show promising new treatment for patients with myelodysplastic syndromes
A new study by Yale Cancer Center (YCC) and Smilow Cancer Hospital researchers suggests that the drug venetoclax aids therapy for relapsed/refractory myelodysplastic syndromes, especially when paired with azacytidine.
New CSC Facility Improves Access, Promotes Collaboration, and Provides Welcoming Space for Kids and Families
The Yale Child Study Center has opened a new facility that brings all of its clinical operations together under one roof, thereby making it easier for families to access services and promoting increased collaboration among clinicians.
Yale Cancer Center researchers show identifying type of chronic pain in adults with sickle cell disease may lead to better outcomes
Identifying the type of pain an adult with sickle cell disease (SCD) experiences may be useful in improving treatment, according to a new study by researchers at Yale Cancer Center (YCC) and Smilow Cancer Hospital.